Q1 2015 13F Holders as of 31 Mar 2015
-
Type / Class
-
Equity / NY ARCA BIOTECH
-
Number of holders
-
119
-
Total 13F shares, excl. options
-
16,117,838
-
Shares change
-
+3,721,577
-
Total reported value, excl. options
-
$1,905,196,132
-
Value change
-
+$443,224,811
-
Put/Call ratio
-
72%
-
Number of buys
-
82
-
Number of sells
-
-40
-
Price
-
$118.23
Significant Holders of FIRST TR EXCHANGE-TRADED FD - NY ARCA BIOTECH (FBT) as of Q1 2015
138 filings reported holding FBT - FIRST TR EXCHANGE-TRADED FD - NY ARCA BIOTECH as of Q1 2015.
FIRST TR EXCHANGE-TRADED FD - NY ARCA BIOTECH (FBT) has 119 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 16,117,838 shares
.
Largest 10 shareholders include FIRST TRUST ADVISORS LP (5,797,055 shares), MORGAN STANLEY (2,690,005 shares), WELLS FARGO & COMPANY/MN (2,151,141 shares), UBS Group AG (995,536 shares), BANK OF AMERICA CORP /DE/ (779,557 shares), GOLDMAN SACHS GROUP INC (450,226 shares), RAYMOND JAMES & ASSOCIATES (377,495 shares), LPL Financial LLC (331,410 shares), ROYAL BANK OF CANADA (217,671 shares), and Ameriprise Financial Inc (122,187 shares).
This table shows the top 119 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.